Astena Holdings Co., Ltd. manufactures and sells medicine-related products in Japan. The company’s Fine Chemical division deals in the chemistry, manufacturing and control (CMC)/contract development and manufacturing organization (CDMO) and procurement platform businesses; and offers services for pharmaceutical development and manufacturing, from raw ingredient procurement to CMC research and development and commercial API production for antipyretic, analgesic and anti-inflammatory, and vasoconstrictor areas. The company’s Health & Beauty Care, and Food division delivers OTC drugs, functional food and cosmetic ingredients, and conducts mail-order sales of cosmetics and OEM products, including 1,3-butylene glycol, sodium acetylated hyaluronate, yeast extract, tomato powder, natural plant extract, natural plant extract, dehydrate potato, and meat extract powder. Its Medical division manufactures and sells semi-solid products, consisting of ointments, creams, and lotions; solid products comprising tablets and powders for the generic drug market. Its Industrial Chemicals division manufactures and sells surface finishing chemicals and other chemical products, such as products for PWBs, electronic devices, general platings, and semiconductors. The company was formerly known as Iwaki & Co., Ltd. and changed its name to Astena Holdings Co., Ltd. in June 2021. Astena Holdings Co., Ltd. was founded in 1914 and is headquartered in Chuo, Japan.
Metrics to compare | 8095 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship8095PeersSector | |
---|---|---|---|---|
P/E Ratio | −7.4x | 12.7x | −0.5x | |
PEG Ratio | 0.02 | 0.14 | 0.00 | |
Price / Book | 0.7x | 1.2x | 2.6x | |
Price / LTM Sales | 0.3x | 1.6x | 3.0x | |
Upside (Analyst Target) | - | 19.5% | 54.9% | |
Fair Value Upside | Unlock | 17.7% | 9.8% | Unlock |